NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Battery Technology


Return to Library

Free Battery Technology Articles


EnerDel Awarded $3.3 Million for Safety Research on Auto Lithium-ion Battery



2009 JUL 7 - (NewsRx.com) -- Advanced lithium-ion automotive battery developer EnerDel has been awarded up to $3.3 million for a cost-share research project under the U.S. Department of Energy. This will be the largest of a set of new projects announced under DOE's Vehicle Technologies Program, and will focus on the development of innovative technologies to eliminate overcharging in lithium-ion cells.

The program is separate from the Department's Advanced Technology Vehicle Manufacturing loan program and Advanced Battery Manufacturing Initiative grant program, where Ener1 also has applications pending for large-scale expansion of its domestic manufacturing capacity.

"EnerDel is deeply committed to the continuous improvement of advanced lithium-ion automotive battery technology," said EnerDel CEO Ulrik Grape. "This award by the Department of Energy will help us enhance the reliability, safety and performance characteristics of lithium-ion batteries and widen their scope of commercial application."

The project will be conducted jointly with Argonne National Laboratories in Chicago and will focus on a new chemical additive that acts as a "shuttle agent" to effectively cap the voltage of the cell. The additive transports the charge through the cell once the desired voltage is reached. Overcharging cells in pack systems is normally monitored with voltage monitoring circuits. Refining this at the base chemistry level of the cell will vastly improve reliability and overall pack efficiency.

"This project gives us the opportunity to work with our partners at EnerDel to push the boundaries of next-generation battery technology, to produce tangible benefits for the industry and ultimately the consumer," said Khalil Amine, senior scientist and manager of the advanced battery technology group at Argonne.

The close relationship between EnerDel and Argonne is setting the standard for collaboration with the U.S. national research laboratories. The lithium-titanate chemistry which EnerDel combines with a lithium manganese oxide spinel-based cathode for its hybrid electric vehicle offering was originally developed in partnership with Argonne, and recently received the Excellence in Technology Transfer award.

"It is unquestionably the safest, among the most reliable and lowest cost lithium-ion battery on the market for HEVs," Amine said.

In total, seven projects under this program were awarded by the DOE ranging from $500,000 to $3.3 million and will be conducted over the next three years. All of them will focus on aspects of improving battery material performance or decreasing cost.

Keywords: Ener1, Inc., Automobiles, Chemicals, Chemistry, Department Of Energy, Electronics, Energy, Oil & Gas, Technology, Transportation, VoltageLithium, Therapy, Treatment

This article was prepared by Drug Law Weekly editors from staff and other reports. Copyright 2009, Drug Law Weekly via NewsRx.com.

NewsRx NewsRx NewsRx
-----------------------
PR Login